241 related articles for article (PubMed ID: 35831234)
1. Health Outcomes Associated With Having an Oophorectomy Versus Retaining One's Ovaries for Transmasculine and Gender Diverse Individuals Treated With Testosterone Therapy: A Systematic Review.
Kumar S; Mukherjee S; O'Dwyer C; Wassersug R; Bertin E; Mehra N; Dahl M; Genoway K; Kavanagh AG
Sex Med Rev; 2022 Oct; 10(4):636-647. PubMed ID: 35831234
[TBL] [Abstract][Full Text] [Related]
2. Health Outcomes Associated With Having an Oophorectomy Versus Retaining One's Ovaries for Transmasculine and Gender Diverse Individuals Treated With Testosterone Therapy: A Systematic Review.
Kumar S; Mukherjee S; O'Dwyer C; Wassersug R; Bertin E; Mehra N; Dahl M; Genoway K; Kavanagh AG
Sex Med Rev; 2022 Oct; 10(4):636-647. PubMed ID: 37051961
[TBL] [Abstract][Full Text] [Related]
3. Serum estradiol levels decrease after oophorectomy in transmasculine individuals on testosterone therapy.
Kumar S; Bertin E; O'Dwyer C; Khorrami A; Wassersug R; Mukherjee S; Mehra N; Dahl M; Genoway K; Kavanagh AG
Asian J Androl; 2023; 25(3):309-313. PubMed ID: 36124534
[TBL] [Abstract][Full Text] [Related]
4. Retrospective review of changes in testosterone dosing and physiologic parameters in transgender and gender-diverse individuals following hysterectomy with and without oophorectomy.
Grimstad FW; Fraiman E; Garborcauskas G; Ferrando CA
J Sex Med; 2023 Apr; 20(5):690-698. PubMed ID: 36987750
[TBL] [Abstract][Full Text] [Related]
5. Ovarian Histopathology in Transmasculine Persons on Testosterone: A Multicenter Case Series.
Grimstad FW; Fowler KG; New EP; Ferrando CA; Pollard RR; Chapman G; Gray M; Gomez Lobo V
J Sex Med; 2020 Sep; 17(9):1807-1818. PubMed ID: 32703706
[TBL] [Abstract][Full Text] [Related]
6. Young Adult Patients with Testosterone Management Concerns after Gender-Affirming Hysterectomy and Bilateral Oophorectomy: A Case Series.
Barrera EP; Grimstad FW; Boskey ER
J Pediatr Adolesc Gynecol; 2023 Feb; 36(1):89-91. PubMed ID: 35850361
[TBL] [Abstract][Full Text] [Related]
7. Surgical Menopause and Bilateral Oophorectomy: Effect of Estrogen-Progesterone and Testosterone Replacement Therapy on Psychological Well-being and Sexual Functioning; A Systematic Literature Review.
Stuursma A; Lanjouw L; Idema DL; de Bock GH; Mourits MJE
J Sex Med; 2022 Dec; 19(12):1778-1789. PubMed ID: 36175351
[TBL] [Abstract][Full Text] [Related]
8. Effects of gender-affirming hormone therapy on insulin resistance and body composition in transgender individuals: A systematic review.
Spanos C; Bretherton I; Zajac JD; Cheung AS
World J Diabetes; 2020 Mar; 11(3):66-77. PubMed ID: 32180895
[TBL] [Abstract][Full Text] [Related]
9. Salpingo-oophorectomy at the Time of Benign Hysterectomy: A Systematic Review.
Evans EC; Matteson KA; Orejuela FJ; Alperin M; Balk EM; El-Nashar S; Gleason JL; Grimes C; Jeppson P; Mathews C; Wheeler TL; Murphy M;
Obstet Gynecol; 2016 Sep; 128(3):476-85. PubMed ID: 27500347
[TBL] [Abstract][Full Text] [Related]
10. Functional ovarian reserve in transgender men receiving testosterone therapy: evidence for preserved anti-Müllerian hormone and antral follicle count under prolonged treatment.
Yaish I; Tordjman K; Amir H; Malinger G; Salemnick Y; Shefer G; Serebro M; Azem F; Golani N; Sofer Y; Stern N; Greenman Y
Hum Reprod; 2021 Sep; 36(10):2753-2760. PubMed ID: 34411251
[TBL] [Abstract][Full Text] [Related]
11. The uterus in transgender men.
Carbonnel M; Karpel L; Cordier B; Pirtea P; Ayoubi JM
Fertil Steril; 2021 Oct; 116(4):931-935. PubMed ID: 34364678
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Exogenous Testosterone on Breast Cancer Risk in Transmasculine Individuals.
Gurrala RR; Kumar T; Yoo A; Mundinger GS; Womac DJ; Lau FH
Ann Plast Surg; 2023 Jan; 90(1):96-105. PubMed ID: 36534108
[TBL] [Abstract][Full Text] [Related]
13. Gender-affirming estrogen therapy route of administration and cardiovascular risk: a systematic review and narrative synthesis.
Turino Miranda K; Kalenga CZ; Saad N; Dumanski SM; Collister D; Rytz CL; Lorenzetti DL; Chang DH; McClurg C; Sola DY; Ahmed SB
Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H861-H868. PubMed ID: 36053748
[TBL] [Abstract][Full Text] [Related]
14. Barriers to Evidence-Based Transgender Care: Knowledge Gaps in Gender-Affirming Hysterectomy and Oophorectomy.
Reilly ZP; Fruhauf TF; Martin SJ
Obstet Gynecol; 2019 Oct; 134(4):714-717. PubMed ID: 31503150
[TBL] [Abstract][Full Text] [Related]
15. Reproductive capacity after gender-affirming testosterone therapy.
Kinnear HM; Moravek MB
Hum Reprod; 2023 Oct; 38(10):1872-1880. PubMed ID: 37573140
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
17. HIV prevalence among transmasculine individuals at a New York City Community Health Centre: a cross-sectional study.
Radix AE; Larson EL; Harris AB; Chiasson MA
J Int AIDS Soc; 2022 Oct; 25 Suppl 5(Suppl 5):e25981. PubMed ID: 36225145
[TBL] [Abstract][Full Text] [Related]
18. Vaginal self-lubrication following peritoneal, penile inversion, and colonic gender-affirming vaginoplasty: a physiologic, anatomic, and histologic review.
O'Dwyer C; Kumar S; Wassersug R; Khorrami A; Mukherjee S; Mankowski P; Genoway K; Kavanagh AG
Sex Med Rev; 2023 Jun; 11(3):212-223. PubMed ID: 37105933
[TBL] [Abstract][Full Text] [Related]
19. The effect of testosterone on ovulatory function in transmasculine individuals.
Taub RL; Ellis SA; Neal-Perry G; Magaret AS; Prager SW; Micks EA
Am J Obstet Gynecol; 2020 Aug; 223(2):229.e1-229.e8. PubMed ID: 32044312
[TBL] [Abstract][Full Text] [Related]
20. Contraception across the transmasculine spectrum.
Krempasky C; Harris M; Abern L; Grimstad F
Am J Obstet Gynecol; 2020 Feb; 222(2):134-143. PubMed ID: 31394072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
